Low natural killer cell cytotoxic activity in autism: The role of glutathione, IL-2 and IL-15

Journal of Neuroimmunology

Volumn 205, Issue 1-2, 2008, Pages 148-154

  Vojdani, Aristo ^a   Mumper, Elizabeth ^b   Granpeesheh, Doreen ^c   Mielke, Lynne ^d   Traver, David ^e   Bock, Kenneth ^f   Hirani, Karima ^g   Neubrander, James ^e   Woeller, Kurt N ^h   O'Hara, Nancy ^e   Usman, Anju ^e   Schneider, Cindy ⁱ   Hebroni, Frank ^a   Berookhim, Joshua ^a   McCandless, Jaquelyn ^e  

^a Immunosciences Laboratories Inc   (United States)

^b Rimland Center   (United States)

^c Center for Autism and Related Disorders   (United States)

^d Developmental Spectrums   (United States)

^e Rhinebeck Health Center ^*  (United States)

^f Rhinebeck Child and Family Center   (United States)

^g Hirani Wellness Center   (United States)

^h Stillpoint Center for Integrative Medicine   (United States)

ⁱ Center for Autism Research and Education   (United States)

Author keywords

Autism; Glutathione; Interleukin 15; Interleukin 2; Natural killer cell

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; GLUTATHIONE; INTERLEUKIN 2; INTERLEUKIN 5;

ADOLESCENT; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADOLESCENT; ANALYSIS OF VARIANCE; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CELL COUNT; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GLUTATHIONE; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE;

EID: 56649089687     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.09.005     Document Type: Article

References (65)

1. + lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173 (2006) 126-134
2. Ashwood P., Anthony A., Torrente F., and Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 24 (2004) 664-673
3. Ashwood P., Wills S., and van de Water J. The immune response in autism: a new frontier for autism research. J. Leukoc. Biol. 80 (2006) 1-15
4. Baird G., Cass H., and Slonims V. Diagnosis of autism. Br. Med. J. 327 (2003) 488-493
5. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17 (1999) 189-220
6. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Activation, coactivation and costimulation of resting human natural killer cells. Immunol. Rev. 214 (2006) 73-91
7. Carson W.E., Fehniger T.A., Subrata H., Eckhert K., Lindemann M.J., Lai C.-F., Croce C.M., Baumann H., and Caligiuri M.A. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99 (1997) 937-943
8. Cohen D., Pichard N., Tordjman S., Baumann C., Burglen L., Excoffier E., Lazar G., Mazet P., Pinquier C., Verloes A., and Heron D. Specific genetic disorders and autism: clinical contribution towards their identification. J. Autism Dev. Disord. 35 (2005) 103-116
9. Colucci F., Caligiuri M.A., and Di Santo J.P. What does it take to make a natural killer?. Nature Rev. Immunology 3 (2003) 413-425
10. Cooper M.A., Fehniger T.A., and Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 22 (2001) 633-640
11. Deniz G., Erten G., Kücüksezer U.C., Kocacik D., Karagiannidis C., Aktas E., Akdis C.A., and Akdis M. Regulatory NK cells suppress antigen-specific T cell responses. J. Immunol. 180 (2008) 850-857
12. Droge W., Pottmeyer-Gerber C., Schmidt H., and Nick S. Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 17 (1986) 151-156
13. Droge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.-P., Roth S., and Gmunder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8 (1994) 1131-1138
14. Edelson S.B., and Cantor D.S. The neurotoxic etiology of the autistic spectrum disorder: a replicative study. Toxicol. Ind. Health 16 (2000) 239-247
15. Farag S.S., and Caligiuri M.A. Human natural killer cell development and biology. Blood Rev. 20 (2006) 123-137
16. Fatemi S.H., Earle J., Kamodia R., Kist D., Emamian E.S., Patterson P.H., Shi L., and Sidwell R.W. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol. 22 (2002) 25-33
17. Fatemi S.H., Snow A.V., Stary J.M., Araghi-Niknam M., Reutiman T.J., Lee S., Brooks A.I., and Pearce D.A. Reelin signaling is impaired in autism. Biol. Psychiatry 57 (2005) 777-787
18. Fehniger T.A., Cooper M.A., and Caligiuri M.A. Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine Growth Factor Rev. 13 (2002) 169-183
19. Fortier J.M., and Kornbluth J. NK lytic-associated molecule, involved in NK cytotoxic function, is an E3 ligase. J. Immunol. 176 (2006) 6454-6463
20. Freitag C.M. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 12 (2007) 2-22
21. Galter D., Mihm S., and Droge W. Distinct effects of glutathione disulfide on the transcription factors NFκN and AP-1. Eur. J. Biochem. 221 (1994) 639-648
22. Gmunder H., and Droge W. Differential effects of glutathione depletion on T cell subsets. Cell. Immunol. 138 (1991) 229-237
23. Gosselin J., Tomolu A., Gallo R.C., and Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 94 (1999) 4210-4219
24. Hallett W.H.D., Ames E., Motarjemi M., Barao I., Shanker A., Tamang D.L., Sayers T.J., Hudig D., and Murphy W.J. Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J. Immunol. 180 (2008) 163-170
25. Hamilos D.L., and Wedner H.J. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J. Immunol. 135 (1985) 2740-2747
26. Hargrove M.E., Wang J., and Ting C.-C. Regulation by glutathione of the activation and differentiation of IL-4-dependent activated killer cells. Cell. Immunol. 149 (1993) 433-443
27. Hayakawa Y., and Smyth M.J. Innate immune recognition and suppression of tumors. Adv. Cancer Res. 95 (2006) 293-322
28. Herberman R.B., Nunn M.E., and Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer. 16 (1975) 216-229
29. Huang C., Bi E., Hu Y., Deng W., Tian Z., Dong C., and Sun B. A novel NF-κB binding site controls human granzyme B gene transcription. J. Immmunol. 176 (2006) 4173-4181
30. Jyonouchi H., Sun S.N., and Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120 (2001) 170-179
31. Johansson S., Berg L., Hall H., and Hoglund P. NK cells: elusive players in autoimmunity. Trend Immunol. 26 (2005) 613-618
32. Kiessling R., Klein E., and Wigzell H. 'Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5 (1975) 112-117
33. Kim H.-G., Kishikawa S., Higgins A.W., Seong I.-S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., Descartes M., Holt L., Braddock S., Troxell R., Kaplan L., Volkmar F., Klin A., Tsatsanis K., Harris D.J., Noens I., Pauls D.L., Daly M.J., MacDonald M.E., Morton C.C., Quade B.J., and Gusella J.F. Disruption of neurexin 1 (NRXN1) associated with autism spectrum disorder. Am. J. Hum. Genet. 82 (2008) 199-207
34. Kinscherf R., Fischbach T., Mihm S., Roth S., Hohenhaus-Sievert E., Weiss C., Edler L., Bartsch P., and Droge W. Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells. FASEB J 8 (1994) 448-451
35. Kozlowski M., Schorey J., Portis T., Grigoriev V., and Kornbluth J. NK lytic associated molecule: a novel gene selectively expressed in cells with cytolytic function. J. Immunol. 163 (1999) 1775-1785
36. Lehmann C., Zeis M., and Uharek L. Activation of natural killer cells with interleukin-2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells. Br. J. Haematol. 114 6 (2001) 660-665
37. Liang C.-M., Lee N., Cattell D., and Liang S.-M. Glutathione regulates interleukin-2 activity on cytotoxic T-cells. J. Biol. Chem. 264 (1989) 13519-13523
38. Ljunggren H.G., and Malmberg K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7 (2007) 329-339
39. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., and Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 172 (2006) 198-205
40. + T cell responses. J. Immunol. 180 (2008) 350-360
41. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.-Q., Liew F.Y., Caligiuri M.A., Durbin J.E., and Biron C.A. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell response to viral infection. J. Immunol. 169 (2002) 4279-4287
42. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin. Immunol. 118 (2006) 1-10
43. Pandey R., DeStephan C.M., Madge L.A., May M.J., and Orange J.S. NKp30 ligation induces rapid activation of the canonical NF-κB pathway in NK cells. J. Immunol. 179 (2007) 7385-7396
44. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nature Immunol. 5 (2004) 996-1002
45. Rose R.C., and Bode A.M. Analysis of water-soluble anti-oxidants by high-pressure chromatography. Biochem. J. 306 (1995) 101-105
46. Rutter M. Genetic studies of autism: from the 1970s into the millennium. J. Abnorm. Child Psychol. 28 (2000) 3-14
47. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., Leotta A., Zhang D.P.R., Lee Y.-H., Hicks J., Spence S.J., Lee A.T., Puura K., Lehtimäki T., Ledbetter D., Gregersen P.K., Bregman J., Sutcliffe J.S., Jobanputra V., Chung W., Warburton D., King M.-C., Skuse D., Geschwind D.H., Gilliam T.C., Ye K., and Wigler M. Strong association of de novo copy number mutations with autism. Science 316 (2007) 445-449
48. Segal B.M. The role of natural killer cells in curbing neuroinflammation. J. Neuroimmunol. 191 (2007) 2-7
49. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23 (2003) 297-302
50. Smyth M.J. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J. Immunol. 146 (1999) 1921-1927
51. Stubbs E.G., and Crawford M.L. Depressed lymphocyte responsiveness in autistic children. J. Autism Child. Schizophr. 7 (1977) 49-55
52. Suthanthiran M., Anderson M.E., Sharma V.K., and Meister A. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3343-3347
53. Valle Blazquez M., Luque I., Collantes E., Aranda E., Solana R., Pena J., and Munoz E. Cellular redox status influences both cytotoxic and NF-κB activation in natural killer cells. Immunology 90 (1997) 455-460
54. Heuser G., and Vojdani A. Enhancement of natural killer cell activity and T and B cell function by buffered vitamin C in patients exposed to toxic chemicals: the role of protein kinase-C. Immunopharmacol. Immunotoxicol. 19 (1997) 291-312
55. Vojdani A., Campbell A.W., Anyanwu E., Kashanian A., Bock K., and Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus Group A. J. Neuroimmunol. 129 (2002) 168-177
56. Vojdani A., Pangborn J.B., Vojdani E., and Cooper E.L. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16 3 (2003) 189-199
57. Vojdani A., Bazargan M., Vojdani E., Samadi J., Nourian A.A., Eghbalieh N., and Cooper E.L. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin. Diag. Lab. Immunol. 11 3 (2004) 515-524
58. Warren R.P., Foster A., Margaretten N.C., Pace N.C., and Foster A. Immune abnormalities in patients with autism. J. Autism Dev. Disord. 16 (1986) 189-197
59. Warren R.P., Foster A., Margaretten N.C., and Pace N.C. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psych. 26 (1987) 333-335
60. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., Platt O.S., Ruderfer D.M., Walsh C.A., Altshuler D., Chakravarti A., Tanzi R.E., Stefansson K., Santangelo S.L., Gusella J.F., Sklar P., Wu B.L., Daly M.J., and Autism Consortium. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358 (2008) 1-9
61. Whiteside T.L., Bryant J., Day R., and Herberman R.B. Natural killer cell cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal. 4 (1990) 102-110
62. Wiznitzer M. Autism and tuberous sclerosis. J. Child Neurol. 19 (2004) 675-679
63. Wu J., and Lanier L.L. Natural killer cells and cancer. Adv. Cancer Res. 90 (2001) 127-156
64. Yamamura T., Sakuishi K., Illes Z., and Miyake S. Understanding the behavior of invariant NKT cells in autoimmune diseases. J. Neuroimmunol. 191 (2007) 8-17
65. Zhou J., Zhang J., Lichtenheld M.G., and Meadows G.G. A role for NF-κB activation in perforin expression of NK cells upon IL-2 receptor signaling. J. Immunol. 169 (2002) 1319-1325